Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Aulos Bioscience, Inc.
ImmunityBio, Inc.
University of Pittsburgh
Vedanta Biosciences, Inc.
Incyte Corporation
Toray Industries, Inc
Fate Therapeutics
Nektar Therapeutics
Incyte Corporation
MultiVir, Inc.